Community Partners

Audits
3
Findings
48
Total Expended
$95.94M
Latest Accepted
2025-03-28
Location: Los Angeles, CA
UEI: N5PHFMM2U468 EIN: 954302067

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Joyce Williams Chief Financial and Operations Officer Auditee
Karen Miessner Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
350249 2024 2025-03-28 Singerlewak LLP $64.24M
299626 2023 2024-03-28 Singerlewak LLP $20.63M
296891 2022 2024-03-22 Singerlewak LLP $11.08M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
299626 2023 2024-03-28 963915 2023-003 Material Weakness - M
299626 2023 2024-03-28 963914 2023-002 Significant Deficiency Yes M
299626 2023 2024-03-28 963913 2023-003 Material Weakness - M
299626 2023 2024-03-28 963912 2023-002 Significant Deficiency Yes M
299626 2023 2024-03-28 387473 2023-003 Material Weakness - M
299626 2023 2024-03-28 387472 2023-002 Significant Deficiency Yes M
299626 2023 2024-03-28 387471 2023-003 Material Weakness - M
299626 2023 2024-03-28 387470 2023-002 Significant Deficiency Yes M
296891 2022 2024-03-22 960315 2022-007 Material Weakness - L
296891 2022 2024-03-22 960314 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 960313 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 960312 2022-004 Material Weakness - H
296891 2022 2024-03-22 960311 2022-007 Material Weakness - L
296891 2022 2024-03-22 960310 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 960309 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 960308 2022-004 Material Weakness - H
296891 2022 2024-03-22 960307 2022-007 Material Weakness - L
296891 2022 2024-03-22 960306 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 960305 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 960304 2022-004 Material Weakness - H
296891 2022 2024-03-22 960303 2022-007 Material Weakness - L
296891 2022 2024-03-22 960302 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 960301 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 960300 2022-004 Material Weakness - H
296891 2022 2024-03-22 960299 2022-007 Material Weakness - L
296891 2022 2024-03-22 960298 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 960297 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 960296 2022-004 Material Weakness - H
296891 2022 2024-03-22 383873 2022-007 Material Weakness - L
296891 2022 2024-03-22 383872 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 383871 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 383870 2022-004 Material Weakness - H
296891 2022 2024-03-22 383869 2022-007 Material Weakness - L
296891 2022 2024-03-22 383868 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 383867 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 383866 2022-004 Material Weakness - H
296891 2022 2024-03-22 383865 2022-007 Material Weakness - L
296891 2022 2024-03-22 383864 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 383863 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 383862 2022-004 Material Weakness - H
296891 2022 2024-03-22 383861 2022-007 Material Weakness - L
296891 2022 2024-03-22 383860 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 383859 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 383858 2022-004 Material Weakness - H
296891 2022 2024-03-22 383857 2022-007 Material Weakness - L
296891 2022 2024-03-22 383856 2022-006 Significant Deficiency - M
296891 2022 2024-03-22 383855 2022-005 Significant Deficiency - B
296891 2022 2024-03-22 383854 2022-004 Material Weakness - H